ReviewClinical and molecular hepatology2026
Post-transplant hepatocellular carcinoma: balancing immunosuppression and immune checkpoint inhibitors.
Tomoharu Yamada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it